Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aminoglycoside-induced cochlear pathology in man.

L G Johnsson, J E Hawkins, T C Kingsley

    Acta Oto-Laryngologica. Supplementum
    |January 1, 1981
    PubMed
    Summary

    Aminoglycoside antibiotics can cause hearing loss by damaging inner ear hair cells. Neomycin, in particular, poses a significant risk to hearing, even with varied administration routes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Early medical abortion by telemedicine in the United Kingdom: a costing analysis.

    BJOG : an international journal of obstetrics and gynaecology·2021
    Same author

    Injury of the inner ear produced by exposure to loud tones.

    Federation proceedings·2010
    Same author

    Further observations on the toxic factor in ischemic compression shock.

    Federation proceedings·2010
    Same author

    Hypotensive reactions to cross-transfusion in dogs.

    Federation proceedings·2010
    Same author

    Cross-circulation studies in ischemic compression shock.

    Proceedings. American Federation for Clinical Research·2010
    Same author

    Vestibular disturbances produced in animals by streptomycin.

    The American journal of the medical sciences·2010

    Area of Science:

    • Ototoxicity research
    • Auditory neuroscience
    • Pharmacology

    Background:

    • Aminoglycosides are crucial antibiotics for treating severe bacterial infections.
    • Hearing loss is a known, yet variable, side effect of aminoglycoside therapy.
    • Understanding the precise mechanisms of aminoglycoside-induced ototoxicity is vital for patient safety.

    Observation:

    • Temporal bones from five patients with aminoglycoside-induced hearing loss were analyzed.
    • Histological examination focused on the cochlea and spiral ganglion.
    • Specific aminoglycosides studied included gentamicin, tobramycin, amikacin, and neomycin.

    Findings:

    • Damage patterns varied, with some patients showing minimal hair cell loss and others extensive degeneration of Corti's organ.
    • Neomycin exposure, regardless of administration route, was associated with severe hair cell loss and spiral ganglion neuron damage.
    • Degeneration was often concentrated in the basal turn of the cochlea, affecting nerve fibers and supporting cells.

    Implications:

    • Neomycin presents a substantial ototoxic risk, necessitating careful monitoring and consideration of alternative therapies.
    • The findings highlight the need for individualized risk assessment in patients undergoing aminoglycoside treatment.
    • Further research into protective strategies against aminoglycoside-induced hearing loss is warranted.

    Related Experiment Videos